caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1912260829

John SchwerkoskeMD

Hematology-OncologyChula Vista, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
1,375
Beneficiaries
—
Total drug cost
$3.7M
Distinct drugs
44
Brand share
25.7%
Top prescribed drugs
Anastrozole220 claims
Letrozole113 claims
Alendronate Sodium66 claims
Famotidine54 claims
Ondansetron Hcl51 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
102
Unique beneficiaries
—
Total services
238
Distinct HCPCS
4
Medicare payment
$22K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — above median (cohort median 4,173).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
167
By payment type
Food and Beverage$4K
Long term medical supply or device loan$382
Education$129